• SENSEX 76,617.44
    592.93 (+0.78%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Kalyan Jewellers
    519.15 794.60(%)
  • Dr Lal Pathlabs
    2,508.00 3,645.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Quadrant Future
    605.00 743.45(%)
  • Zomato Ltd
    212.60 304.50(%)
  • SRF
    2,986.25 3,074.95(%)
  • Bengal & Assam
    7,450.00 11,498.90(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Mazagon Dock
    2,610.00 2,929.98(%)
  • Suzlon Energy
    57.74 86.04(%)
  • SpiceJet
    46.10 79.90(%)
  • Dixon Technolog.
    13,485.00 19,149.80(%)
  • Adani Green
    944.95 2,173.65(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • M & M
    2,660.50 3,276.30(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gufic BioSciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2285.0
  • ISIN : INE742B01025
338.45 2 (0.64%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    326.20

  • Today’s High

    341.85

  • Open

    336.05

  • Perv Close

    336.30

  • 52W Low

    278.00

  • 52W High

    504.25

Key Indicators

  • P/E(TTM)

    41.25

  • Mar.Cap (₹Cr.)

    3,393.89

  • Div & Yield %

    0.03

  • Book Value(₹)

    57.26

  • Debt-Equity Ratio

    0.64

  • AGM Date

    01-Apr-2025

  • EPS

    8.18

  • P/E Ratio

    41.25

Financials Ratios

  • Debt-Equity Ratio

    0.63

  • Mar.Cap (₹Cr.)

    3,393.89

  • RONW (%)

    16.17

  • ROCE (%)

    14.79

Score Board

  • Equity (₹ in Cr.)

    10.03

  • BV (₹)

    57.30

  • Sales( ₹ in Cr.)

    806.67

  • NP (in Cr.)

    87.81

  • NP Var(%)

    10.0

  • Div%

    10.0

  • CPS (₹)

    10.50

  • EPS (₹)

    8.80

  • Traded Value (₹ in Lakhs)

    3,383.36

  • 52 Week High

    504.25

  • 52 Week Low

    278.00

  • Price BSE

    337.0

  • Price NSE

    338.00

  • Market Capital( in Cr.)

    3,383.36

  • P/C Ratio

    32.20

  • P/E Ratio

    38.50

  • Price Vs.BV

    8.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 806.67 690.62 779.16 487.70 378.84 350.77
Excise Duty 769.66 679.75 713.02 433.95 356.58 342.45
Net Sales 806.67 690.62 779.16 487.70 378.84 350.77
Other Income 2.18 2.57 3.10 3.73 5.79 4.17
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 808.84 693.19 782.26 491.43 384.63 354.94
EXPENDITURE :
Raw Materials 769.66 679.75 713.02 433.95 356.58 342.45
Power & Fuel Cost 769.66 679.75 713.02 433.95 356.58 342.45
Employee Cost 109.63 86.73 85.61 66.22 58.59 46.85
Other Manufacturing Expenses 10.75 9.88 17.16 13.20 10.35 6.29
Selling & Administrative Expenses 104.31 87.63 77.97 45.93 54.08 46.29
Miscellaneous Expenses 10.75 9.88 17.16 13.20 10.35 6.29
Less : Pre-operative Expenses Capitalised :
Total Expenditure 693.17 586.47 655.42 433.72 354.50 319.59
Operating Profit 46.22 39.91 38.42 28.14 24.17 24.58
Interest 15.36 8.22 5.37 13.63 13.91 10.16
Gross Profit 115.67 106.72 126.84 57.71 30.13 35.35
Depreciation 17.02 22.28 18.93 16.31 13.86 4.65
Profit Before Tax 115.67 106.72 126.84 57.71 30.13 35.35
Tax 28.40 28.21 32.15 17.20 8.31 11.53
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.17 -1.19 -1.15 2.01 0.88 1.82
Reported Net Profit 86.14 79.70 95.84 44.23 22.69 21.94
Extraordinary Items 115.67 106.72 126.84 57.71 30.13 35.35
Adjusted Net Profit 86.14 79.70 95.84 44.23 22.69 21.94
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 1.00 0.97 0.97 0.97 0.05 0.39
P & L Balance carried down 86.14 79.70 95.84 44.23 22.69 21.94
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 10.00 10.00 10.00 10.00 5.00 5.00
Dividend Per Share(Rs) 0.10 0.10 0.10 0.10 0.05 0.05
Earnings Per Share-Unit Curr 8.74 8.22 9.89 4.56 2.34 2.82
Book Value 1.00 0.97 0.97 0.97 0.05 0.39
Book Value(Adj)-Unit Curr 1.00 0.97 0.97 0.97 0.05 0.39

Shareholding Pattern

  • Promoter Group

    72.51%

  • Public Share Holding

    27.49%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 30,714,853 30.63 30,714,853 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,993,298 41.88 41,993,298 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 72,708,151 72.51 72,708,151 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 305,139 0.30 305,139 21
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,924,332 2.92 2,924,332 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 68,845 0.07 68,845 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,298,316 3.29 3,298,316 30
2] Non Institution
Bodies Corporate 4,984,092 4.97 4,984,092 191
Clearing Members 488 0.00 488 3
Directors of their Relatives 496,045 0.49 496,045 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 600,536 0.60 600,536 710
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,702,650 1.70 1,702,650 640
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,109,640 3.10 3,109,640 4
Individuals holding nominal share capital up to Rs. 1 lakh 12,376,965 12.34 12,351,965 31,695
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 287,045 0.29 287,045 2
Sub Total 24,271,039 24.20 24,246,039 33,264
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 100,277,506 100.00 100,252,506 33,299

Company Background

Gufic BioSciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Gufic BioSciences Ltd
  • BSE Code : 2285.0
  • ISIN : INE742B01025

  • Incorporation Year

    1984

  • Registered Office

    Shop-37 1st Flr Kamala Bhavan
    Swami Nityanand Road Andheri(E, Mumbai,
    Maharashtra-400069

  • Telephone

    91-022-66919187/67261007/66919189

  • FAX

    91-022-26118103/26169008

  • Chairman

    Jayesh P Choksi

  • Managing Director

    Jayesh P Choksi

  • Company Secretary

    Ami Naresh Shah

  • Auditor

    Mittal Agarwal & Company

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    C-13 Pannalal Silk,
    Mills Cmpd LBS Marg,Bhandup West
    Mumbai - Mumbai - 400 078

Gufic BioSciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gufic BioScience 337.40 808.84 806.67 41.25 16.52
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92